FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

20358711000001100: Caprelsa 100mg tablets (Sanofi Genzyme) 30 tablet 3 x 10 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-May 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1912181000001115 Caprelsa 100mg tablets (Sanofi Genzyme) 30 tablet 3 x 10 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1912191000001118 Caprelsa 100mg tablets (Sanofi Genzyme) 30 tablet 3 x 10 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
68780401000001111 Caprelsa 100mg tablets (AstraZeneca UK Ltd) 30 tablet 3 x 10 tablets (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
68780501000001110 Caprelsa 100mg tablets (AstraZeneca UK Ltd) 30 tablet 3 x 10 tablets en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
103738801000001117 Caprelsa 100mg tablets (Genzyme Therapeutics Ltd) 30 tablet 3 x 10 tablets en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Caprelsa 100mg tablets (Sanofi Genzyme) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Caprelsa 100mg tablets (Sanofi Genzyme) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Caprelsa 100mg tablets (Sanofi Genzyme) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring false Inferred relationship Existential restriction modifier
Caprelsa 100mg tablets (Sanofi Genzyme) 30 tablet 3 x 10 tablets Is a Vandetanib 100mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Caprelsa 100mg tablets (Sanofi Genzyme) 30 tablet 3 x 10 tablets Has AMP Caprelsa 100mg tablets (Sanofi Genzyme) true Inferred relationship Existential restriction modifier
Caprelsa 100mg tablets (Sanofi Genzyme) 30 tablet 3 x 10 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Caprelsa 100mg tablets (Sanofi Genzyme) 30 tablet 3 x 10 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Caprelsa 100mg tablets (Sanofi Genzyme) 30 tablet 3 x 10 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Caprelsa 100mg tablets (Sanofi Genzyme) 30 tablet 3 x 10 tablets Has specific active ingredient Vandetanib true Inferred relationship Existential restriction modifier
Caprelsa 100mg tablets (Sanofi Genzyme) 30 tablet 3 x 10 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Caprelsa 100mg tablets (Sanofi Genzyme) 30 tablet 3 x 10 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Caprelsa 100mg tablets (Sanofi Genzyme) 30 tablet 3 x 10 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Caprelsa 100mg tablets (Sanofi Genzyme) 30 tablet 3 x 10 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start